Practical Strategies for Getting Patients With Diabetes to Lipid Goal

Program Goals

Introduction

PCSK9 Inhibition: Mechanism of Action

Discrepancies and Commonalities Between American and European Guidelines

Unmet Need in Diabetes What Treatments Are Available?

Long-Term Efficacy and Safety Alirocumab ODYSSEY COMBO Studies

ODYSSEY COMBO Studies Prespecified Analysis at 52 Weeks

Efficacy and Safety of Alirocumab in Individual With Diabetes Analyses from ODYSSEY Combo Long-Term Study

Conclusions

Abbreviations

Abbreviations (cont)

References

References (cont)

References (cont)